COPD management typically involves medications like bronchodilators, which ease breathing by relaxing airway muscles. The ...

Discover how moderate-to-vigorous physical activity can reduce exacerbations and corticosteroid use in COPD patients on dual ...

Verona Pharma has seen its share price skyrocket in anticipation of the commercial launch of its COPD treatment.

Dubai: The first biological treatment for chronic obstructive pulmonary disease (COPD), now available in the UAE, offers new ...

Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3Through October more than 2,200 unique ...

Do cough, cold or other respiratory issues disrupt your sleep in the rising air pollution? Explore the best nebulizer ...

There is no cure for COPD, but it can be managed and treated by working with your healthcare team to develop a plan to keep your COPD under control. Along with quitting smoking, staying up to date ...

Total Revenue of $93.4 Million for the Third Quarter of 2024, Reflecting 18% Growth Over the Third Quarter of 2023- -NDA Submission for Brensocatib in Bronchiectasis Remains on Track for the Fourth ...

As Diwali is here, Delhi's air quality worsens, and the city's residents, especially those with respiratory issues like COPD, brace for a challenging season. With air quality index (AQI) levels diving ...

A NEW multicenter study, TOReTO, has shown that dual bronchodilator therapy can help reduce exacerbations in patients with chronic obstructive pulmonary disease (COPD), with notable differences in ...

Formoterol (brand names Perforomist, Foradil) is a bronchodilator in a class of medications called long-acting beta agonists (LABAs). It is used to control wheezing, shortness of breath, coughing and ...